Net Sales decreased 0.3%, Organic Sales
increased 0.6%
Significant Gross Margin
Expansion
GAAP EPS decreased 4%, Adjusted EPS
increased 23%
Updates Full Year Outlook
SHELTON,
Conn., Aug. 6, 2024 /PRNewswire/ --
Edgewell Personal Care Company (NYSE: EPC) today announced
results for its third fiscal quarter 2024 ended June 30,
2024.
Executive Summary
- Net sales were $647.8 million, a
decrease of 0.3% compared to the prior year quarter.
- Organic net sales increased 0.6% (Organic basis excludes the
impact from currency movements.)
- GAAP Diluted Net Earnings Per Share ("EPS") were $0.98, compared to $1.02 in the prior year quarter.
- Adjusted EPS were $1.22, compared
to $0.99 in the prior year
quarter.
- Ended the third quarter with $196.1
million in cash on hand, access to an additional
$369.7 million revolving credit
facility and a net debt leverage ratio of 3.1x.
- Returned $17.4 million to
shareholders in the form of $9.9
million in share repurchases and $7.5
million of dividends in the third quarter.
- The Board of Directors declared a cash dividend of $0.15 per common share on August 6, 2024 for the third quarter.
The Company reports and forecasts results on a GAAP and
non-GAAP basis and has reconciled non-GAAP results and outlook to
the most directly comparable GAAP measures later in this release.
See non-GAAP Financial Measures for a more detailed explanation,
including definitions of various non-GAAP terms used in this
release. All comparisons used in this release are for the
same period in the prior fiscal year unless otherwise
stated.
"Our third quarter results reflected robust gross margin
accretion leading to substantial adjusted EBITDA and earnings per
share growth. Amidst a competitive and dynamic market landscape,
organic net sales growth featured continued strength in our
Right-to-Win portfolio, propelled by our industry-leading
Sun Care and Grooming businesses.
Our international businesses sustained their momentum, achieving
significant growth through a balanced mix of pricing and volume
improvements. Crucially, we achieved over 160-basis points of
adjusted gross margin accretion, driven by our steadfast commitment
to cost productivity and strategic revenue management initiatives,"
stated Rod Little, Edgewell's
President and Chief Executive Officer. "Reflecting on our
performance to date, while we now anticipate concluding the year
with sales growth of about 1% and slightly below our previously
forecasted range, we are increasing our full year projections for
adjusted EPS and EBITDA. Our transformation that began just over
three years ago continues to yield positive results. In order to
accelerate our progress across key priorities, we announced, in a
separate press release today, key changes to enhance our leadership
team and simplify our operating model. I'm confident that these
changes will strengthen our business and better position Edgewell
for sustainable top and bottom-line growth," concluded Mr.
Little.
Fiscal 3Q 2024 Operating Results (Unaudited)
Net sales were $647.8
million in the quarter, a decrease of 0.3%, including a
$6.2 million unfavorable impact from
currency movements. Organic net sales increased 0.6%, as continued
strong performance in International markets as well as growth in
our Right to Win portfolio of Sun
Care and Grooming were partially offset by declines in North
America Wet Shave and Feminine Care. In aggregate, increased
pricing and revenue management more than offset the impact of lower
volumes in North America.
Gross profit was $287.1
million, as compared to $280.3
million in the prior year quarter. Gross margin as a
percent of net sales increased 120-basis points, to 44.3% in the
quarter. Adjusted gross margin, as a percent of net sales,
increased 160-basis points, as productivity savings of
approximately 225-basis points and the benefit of higher pricing
and strategic revenue management of approximately 110-basis points
more than offset core inflation and lower volume absorption of
approximately 60-basis points, unfavorable mix and other of
approximately 100-basis points and an unfavorable currency impact
of approximately 15-basis points.
Advertising and sales promotion expense
("A&P") was $76.6
million, or 11.8% of net sales, a decrease of $3.4 million, compared to $80.0 million, or 12.3%, of net sales in the
prior year quarter, reflecting a re-allocation of brand investment
from A&P into increased trade promotion and consumer activation
spend.
Selling, general and administrative expense
("SG&A") was $110.1
million, or 17.0% of net sales, as compared to $96.3 million, or 14.8% of net sales in the prior
year quarter. Adjusted SG&A was 16.2% of net sales, an increase
of 50-basis points, primarily driven by higher people expenses and
legal costs, partially offset by operational efficiency savings,
lower bad debt and favorable currency impacts.
The Company recorded pre-tax restructuring and re-positioning
expenses and costs in support of cost efficiency and effectiveness
programs of $4.9 million in the
quarter, a charge related to a legal matter of $2.5 million, and acquisition and integration
costs related to the Billie acquisition of $0.7 million.
Operating income, was $82.7
million, inclusive of a $2.3
million unfavorable impact from currency movements, compared
to $86.2 million in the prior year
quarter. Adjusted operating income was $94.8
million, or 14.6% of net sales, compared to $84.1 million, or 12.9% of net sales in the prior
year quarter. Adjusted operating margin increased 170-basis points,
reflecting higher gross margin.
Interest expense associated with debt was
$18.8 million, compared to
$19.2 million in the prior year
quarter. The decrease in interest expense was the result of a lower
overall debt balance on the Company's revolving credit facility,
partially offset by higher interest rates.
Other expense (income), net was expense of $1.4 million compared to income of $3.8 million in the prior year quarter. The
current year quarter included a loss on investment of $3.1 million.
The effective tax rate for the first nine months of
fiscal 2024 was 22.2% compared to 25.9% in the prior year period.
The adjusted effective tax rate for the first nine months of fiscal
2024 was 22.3%, down from the prior year period adjusted effective
tax rate of 25.9%. The fiscal 2024 effective tax rate reflects the
favorable mix of earnings in lower tax rate jurisdictions and the
impact of a change in the Company's prior estimates.
GAAP net earnings were $49.0
million or $0.98 per diluted
share compared to $53.0 million or
$1.02 per diluted share in the prior
year quarter. Adjusted net earnings were $61.2 million or $1.22 per share, inclusive of a $0.06 unfavorable currency impact, compared to
$51.3 million or $0.99 per share in the prior year quarter.
Adjusted EBITDA was $117.2 million,
inclusive of a $4.0 million
unfavorable currency impact, compared to $109.7 million in the prior year
quarter.
Net cash provided by operating activities was
$157.3 million for the nine
months ending June 30, 2024, compared to $168.3 million in the prior year period. The
decrease in cash provided by operating activities was largely
driven by changes in net working capital, partially offset by
increased earnings.
Capital Allocation
On August 6, 2024, the Board of
Directors declared a quarterly cash dividend of $0.15 per common share for the third fiscal
quarter of fiscal 2024. The dividend will be payable on
October 3, 2024 to shareholders of
record as the close of business on September
4, 2024. During the third quarter of fiscal 2024, the
Company paid dividends totaling $7.5
million to stockholders and completed share repurchases of
approximately 0.3 million shares at a total cost of $9.9 million. As of June
30, 2024, the Company had 3.5 million shares of common stock
available for repurchase in the future under the Board's 2018
authorization.
Fiscal 3Q 2024 Operating Segment Results (Unaudited)
Wet Shave (Men's Systems, Women's Systems, Disposables,
and Shave Preps)
Net sales decreased $7.8 million, or
2.4%. Organic net sales decreased $2.0
million or 0.6%, as growth in international markets, driven
by both higher volumes and price, was more than offset by volume
declines in North America.
North America sales were impacted
by continued weak category and channel dynamics, particularly in
the highly promotional drug channel, along with heightened
competitive dynamics in Women's shave, as well as significant
declines in Shave Preps. Wet Shave segment profit increased
$15.3 million, or 47.4%. Organic
segment profit, excluding the unfavorable impact from currency
increased $17.5 million, or 54.2%,
reflecting higher gross margins and lower marketing
expenses.
Sun and Skin Care (Sun
Care, Wet Ones, Bulldog, Jack
Black and Cremo)
Net sales increased $12.0 million, or
4.9%. Organic net sales increased $12.4
million, or 5.1%, driven by Sun
Care growth across both international and North America markets, as well as double-digit
growth in Grooming. Sun Care growth
reflected modest growth in North
America, reflecting weak early-season U.S. weather dynamics,
followed by a very strong month of June. Sun and Skin segment
profit increased $2.8 million, or
4.6%, with minimal currency impact, primarily driven by higher
gross margins, partly offset by higher marketing and SG&A
expenses.
Feminine Care (Tampons, Pads, and Liners)
Net sales decreased $6.4 million, or
7.9% with minimal currency impact, largely driven by a decline in
Tampons and Pads, partly offset by growth in Liners. Segment profit
decreased $7.4 million, or 52.9%.
Organic segment profit decreased $7.4
million, or 52.9%, with minimal currency impact, primarily
driven by lower sales and the resulting impact on gross profit as
well has higher marketing expenses.
Full Fiscal Year 2024 Financial Outlook
The Company is providing the following outlook assumptions for
fiscal 2024:
- Organic net sales are now expected to increase approximately 1%
(previously 2%)
- Currency is now expected to negatively impact reported net
sales by 35-basis points (previously, no impact)
- GAAP EPS is now expected to be approximately $2.28 (previously in the range of $2.20 to $2.40)
- Includes: Restructuring and re-positioning charges*,
Acquisition and integration costs, Sun
Care reformulation, costs related to the Wet One's
manufacturing plant fire, a Legal matter charge, Loss on an
investment, and Other costs
- Adjusted EPS is now expected to be approximately $3.00 (previously in the range of range of
$2.80 to $3.00)
- Includes an estimated $0.12 per
share unfavorable impact from foreign currency movements
(previously $0.17 per share
unfavorable impact)
- Adjusted gross margin is now expected to increase approximately
140-basis points to the prior year (previously 120-basis
points)
- This EPS outlook reflects the impact of share repurchases of
approximately $50 million
- Adjusted EBITDA is now expected to be approximately
$356 million (previously in the range
of $348 to $360 million)
- Includes an estimated $8 million
unfavorable impact from foreign currency changes (previously
$11 million unfavorable impact)
- Other Expense, net is expected to be approximately zero
(previously expense of $3
million)
- Interest expense associated with debt is expected to be
approximately $77 million (previously
$78 million)
- Adjusted effective tax rate is expected to be approximately
22%
- Total depreciation and amortization expense expected to be
approximately $90 million (previously
$92 million)
- Capital expenditures expected to be approximately 2.5% of net
sales
- Free cash flow is expected to be approximately $170 million
* In fiscal 2024, the Company is taking specific actions to
strengthen its operating model, simplify the organization and
improve manufacturing and supply chain efficiency through
restructuring and re-positioning actions. As a result of these
actions, the Company expects to incur pre-tax charges of
approximately $19 million for the
full fiscal year.
Webcast Information
In conjunction with this announcement, the Company will hold an
investor conference call beginning at 8:00
a.m. Eastern Time today. All interested parties may access a
live webcast of this conference call at www.edgewell.com, under the
"Investors," and "News and Events" tabs or by using the following
link: http://ir.edgewell.com/news-and-events/events
For those unable to participate during the live webcast, a
re-play will be available on www.edgewell.com, under the
"Investors," "Financial Reports," and "Quarterly Earnings"
tabs. This release includes references to the Company's
website and references to additional information and materials
found on its website. The Company's website and such information
and materials are not incorporated by reference in, and are not
part of, this release.
About Edgewell
Edgewell is a leading pure-play consumer products company with
an attractive, diversified portfolio of established brand names
such as Schick®, Wilkinson Sword® and Billie® men's and women's
shaving systems and disposable razors; Edge and Skintimate® shave
preparations; Playtex®, Stayfree®, Carefree® and o.b.® feminine
care products; Banana Boat®, Hawaiian Tropic®, Bulldog®, Jack
Black®, and CREMO® sun and skin care products; and Wet Ones®
products. The Company has a broad global footprint and operates in
more than 50 markets, including the U.S., Canada, Mexico, Germany, Japan, the U.K. and Australia, with approximately 6,800 employees
worldwide.
# # #
Forward-Looking Statements. This document contains
"forward-looking statements" within the meaning of Section 27A of
the Securities Act of 1933 and Section 21E of the Securities
Exchange Act of 1934. You should not place undue reliance on these
statements. Forward-looking statements generally can be identified
by the use of words or phrases such as "believe," "expect,"
"expectation," "anticipate," "may," "could," "intend," "belief,"
"estimate," "plan," "target," "predict," "likely," "will,"
"should," "forecast," "outlook," or other similar words or phrases.
These statements are not based on historical facts, but instead
reflect the Company's expectations, estimates or projections
concerning future results or events, including, without limitation,
the future earnings and performance of Edgewell or any of its
businesses. Many factors outside our control could affect the
realization of these estimates. These statements are not guarantees
of performance and are inherently subject to known and unknown
risks, uncertainties and assumptions that are difficult to predict
and could cause the Company's actual results to differ materially
from those indicated by those statements. The Company cannot assure
you that any of its expectations, estimates or projections will be
achieved. The forward-looking statements included in this document
are only made as of the date of this document and the Company
disclaims any obligation to publicly update any forward-looking
statement to reflect subsequent events or circumstances, except as
required by law. You should not place undue reliance on these
statements.
In addition, other risks and uncertainties not presently known
to the Company or that it presently considers immaterial could
significantly affect the accuracy of any such forward-looking
statements. Risks and uncertainties include those detailed from
time to time in the Company's publicly filed documents, including
in Item 1A. Risk Factors of Part I of the Company's Annual Report
on Form 10-K filed with the Securities and Exchange Commission on
November 28, 2023.
Non-GAAP Financial Measures. While the Company reports
financial results in accordance with generally accepted accounting
principles ("GAAP") in the U.S., this discussion also includes
non-GAAP measures. These non-GAAP measures are referred to as
"adjusted" or "organic" and exclude items which are considered by
the Company as unusual or non-recurring and which may have a
disproportionate positive or negative impact on the Company's
financial results in any particular period. Reconciliations of
non-GAAP measures, including reconciliations of measures related to
the Company's fiscal 2024 financial outlook, are included within
the Notes to Condensed Consolidated Financial Statements included
with this release.
This non-GAAP information is provided as a supplement to, not as
a substitute for, or as superior to, measures of financial
performance prepared in accordance with GAAP. The Company uses this
non-GAAP information internally to make operating decisions and
believes it is helpful to investors because it allows more
meaningful period-to-period comparisons of ongoing operating
results. The information can also be used to perform analysis and
to better identify operating trends that may otherwise be masked or
distorted by the types of items that are excluded. This non-GAAP
information is a component in determining management's incentive
compensation. Finally, the Company believes this information
provides a higher degree of transparency. The following provides
additional detail on the Company's non-GAAP measures:
- The Company utilizes "adjusted" non-GAAP measures including
gross profit, SG&A, operating income, income taxes, net
earnings, diluted earnings per share, and EBITDA to internally make
operating decisions.
- Constant currency measures are calculated by removing the
impact of translational and transactional foreign currencies
changes, net of foreign currency hedges compared to the prior year.
Transactional foreign currency changes are driven by foreign legal
entities' transactions not denominated in local currency.
- The Company analyzes its net sales and segment profit on an
organic basis to better measure the comparability of results
between periods. Organic net sales and organic segment profit
exclude the impact of changes in foreign currency and the impact of
acquisitions.
- Segment profit will be impacted by fluctuations in translation
and transactional foreign currency. The impact of currency was
applied to segments using management's best estimate.
- Free cash flow is defined as net cash from operating
activities, less capital expenditures plus collections of deferred
purchase price of accounts receivable sold and proceeds from sales
of fixed assets. Free cash flow conversion is defined as free cash
flow as a percentage of net earnings adjusted for the net impact of
non-cash impairments.
- Net debt is defined as Gross debt less cash. Net debt leverage
ratio is defined as net debt less cash divided by trailing twelve
month adjusted EBITDA.
Basis of Presentation. Please refer to the Annual
Report on Form 10-K filed with the Securities and Exchange
Commission on November 28, 2023, for
a revision of previously issued consolidated financial statements,
which may impact year over year results or future estimates
included in this release.
EDGEWELL PERSONAL CARE COMPANY
|
CONDENSED
CONSOLIDATED STATEMENTS OF EARNINGS
|
(unaudited, in
millions, except per share data)
|
|
|
Three Months
Ended
June
30,
|
|
Nine Months
Ended
June
30,
|
|
2024
|
|
2023
|
|
2024
|
|
2023
|
Net sales
|
$
647.8
|
|
$
650.0
|
|
$
1,736.1
|
|
$
1,717.5
|
Cost of products
sold
|
360.7
|
|
369.7
|
|
993.2
|
|
1,005.3
|
Gross
profit
|
287.1
|
|
280.3
|
|
742.9
|
|
712.2
|
|
|
|
|
|
|
|
|
Selling, general and
administrative expense
|
110.1
|
|
96.3
|
|
320.9
|
|
297.2
|
Advertising and sales
promotion expense
|
76.6
|
|
80.0
|
|
187.9
|
|
188.8
|
Research and
development expense
|
14.6
|
|
14.8
|
|
42.1
|
|
42.6
|
Restructuring
charges
|
3.1
|
|
3.0
|
|
13.1
|
|
8.7
|
Operating
income
|
82.7
|
|
86.2
|
|
178.9
|
|
174.9
|
Interest expense
associated with debt
|
18.8
|
|
19.2
|
|
59.0
|
|
59.8
|
Other expense (income),
net
|
1.4
|
|
(3.8)
|
|
4.4
|
|
0.7
|
Earnings before
income taxes
|
62.5
|
|
70.8
|
|
115.5
|
|
114.4
|
Income tax
provision
|
13.5
|
|
17.8
|
|
25.7
|
|
29.6
|
Net
earnings
|
$
49.0
|
|
$
53.0
|
|
$
89.8
|
|
$
84.8
|
|
|
|
|
|
|
|
|
Earnings per
share:
|
|
|
|
|
|
|
|
Basic net earnings per share
|
$
0.99
|
|
$
1.04
|
|
$
1.80
|
|
$
1.65
|
Diluted net earnings per share
|
$
0.98
|
|
$
1.02
|
|
$
1.79
|
|
$
1.63
|
|
|
|
|
|
|
|
|
Weighted-average
shares outstanding:
|
|
|
|
|
|
|
|
Basic
|
49.5
|
|
51.1
|
|
49.8
|
|
51.3
|
Diluted
|
50.1
|
|
51.8
|
|
50.3
|
|
51.9
|
|
See Accompanying
Notes.
|
EDGEWELL PERSONAL CARE COMPANY
|
CONDENSED
CONSOLIDATED BALANCE SHEETS
|
(unaudited, in
millions)
|
|
|
June 30,
2024
|
|
September
30,
2023
|
Assets
|
|
|
|
Current
assets
|
|
|
|
Cash and cash
equivalents
|
$
196.1
|
|
$
216.4
|
Trade receivables,
less allowance for doubtful accounts
|
155.0
|
|
106.2
|
Inventories
|
455.9
|
|
492.4
|
Other current
assets
|
151.7
|
|
147.4
|
Total current
assets
|
958.7
|
|
962.4
|
Property, plant and
equipment, net
|
325.4
|
|
337.9
|
Goodwill
|
1,333.2
|
|
1,331.4
|
Other intangible
assets, net
|
952.2
|
|
973.8
|
Other assets
|
138.9
|
|
135.2
|
Total
assets
|
$
3,708.4
|
|
$
3,740.7
|
|
|
|
|
Liabilities and
Shareholders' Equity
|
|
|
|
Current
liabilities
|
|
|
|
Notes
payable
|
$
21.4
|
|
$
19.5
|
Accounts
payable
|
208.7
|
|
194.4
|
Other current
liabilities
|
305.0
|
|
309.5
|
Total current
liabilities
|
535.1
|
|
523.4
|
Long-term
debt
|
1,290.4
|
|
1,360.7
|
Deferred income tax
liabilities
|
137.3
|
|
136.4
|
Other
liabilities
|
169.0
|
|
179.7
|
Total
liabilities
|
2,131.8
|
|
2,200.2
|
Shareholders'
equity
|
|
|
|
Common
shares
|
0.7
|
|
0.7
|
Additional paid-in
capital
|
1,580.8
|
|
1,593.8
|
Retained
earnings
|
1,089.0
|
|
1,022.1
|
Common shares in
treasury at cost
|
(920.6)
|
|
(906.1)
|
Accumulated other
comprehensive loss
|
(173.3)
|
|
(170.0)
|
Total shareholders'
equity
|
1,576.6
|
|
1,540.5
|
Total liabilities
and shareholders' equity
|
$
3,708.4
|
|
$
3,740.7
|
|
See Accompanying
Notes.
|
EDGEWELL PERSONAL CARE COMPANY
|
CONDENSED
CONSOLIDATED STATEMENTS OF CASH FLOWS
|
(unaudited, in
millions)
|
|
|
Nine Months
Ended
June 30,
|
|
2024
|
|
2023
|
Cash Flow from
Operating Activities
|
|
|
|
Net
earnings
|
$
89.8
|
|
$
84.8
|
Depreciation and
amortization
|
66.6
|
|
68.1
|
Share-based
compensation expense
|
20.4
|
|
19.8
|
Loss on sale of
assets
|
0.3
|
|
1.1
|
Defined benefit
settlement loss
|
—
|
|
7.2
|
Deferred compensation
payments
|
(1.6)
|
|
(4.9)
|
Deferred income
taxes
|
1.3
|
|
(0.6)
|
Other, net
|
(11.0)
|
|
(13.6)
|
Changes in current
assets and liabilities used in operations
|
(8.5)
|
|
6.4
|
Net cash provided by
operating activities
|
$
157.3
|
|
$
168.3
|
|
|
|
|
Cash Flow from
Investing Activities
|
|
|
|
Capital
expenditures
|
$
(30.6)
|
|
$
(31.1)
|
Collection of deferred
purchase price on accounts receivable sold
|
0.2
|
|
1.5
|
Other, net
|
(6.5)
|
|
(2.0)
|
Net cash used by
investing activities
|
$
(36.9)
|
|
$
(31.6)
|
|
|
|
|
Cash Flow from
Financing Activities
|
|
|
|
Cash proceeds from
debt with original maturities greater than 90 days
|
$
633.0
|
|
$
645.0
|
Cash payments on debt
with original maturities greater than 90 days
|
(705.0)
|
|
(715.0)
|
Proceeds from debt
with original maturities of 90 days or less
|
1.9
|
|
5.1
|
Repurchase of
shares
|
(40.2)
|
|
(45.2)
|
Dividends to common
shareholders
|
(23.3)
|
|
(23.8)
|
Net financing inflow
from the Accounts Receivable Facility
|
4.3
|
|
9.6
|
Employee shares
withheld for taxes
|
(7.1)
|
|
(9.0)
|
Other, net
|
(2.9)
|
|
1.0
|
Net cash used by
financing activities
|
$
(139.3)
|
|
$
(132.3)
|
|
|
|
|
Effect of exchange rate
changes on cash
|
(1.4)
|
|
14.3
|
|
|
|
|
Net (decrease) increase
in cash and cash equivalents
|
(20.3)
|
|
18.7
|
Cash and cash
equivalents, beginning of period
|
216.4
|
|
188.7
|
Cash and cash
equivalents, end of period
|
$
196.1
|
|
$
207.4
|
|
See Accompanying
Notes.
|
EDGEWELL PERSONAL CARE COMPANY
NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited,
in millions, except per share data)
Note 1 — Segments
The Company conducts its
business in the following three segments: Wet Shave, Sun and Skin
Care, and Feminine Care (collectively, the "Segments," and each
individually, a "Segment"). Segment performance is evaluated based
on segment profit, exclusive of general corporate expenses,
share-based compensation costs, items which are considered by the
Company to be unusual or non-recurring and which may have a
disproportionate positive or negative impact on the Company's
financial results in any particular period and the amortization of
intangible assets. Financial items, such as interest income and
expense, are managed on a global basis at the corporate level. The
exclusion of such charges from segment results reflects
management's view on how it evaluates segment performance.
Segment net sales and profitability are presented below:
|
Three Months
Ended
June 30,
|
|
Nine Months
Ended
June 30,
|
|
2024
|
|
2023
|
|
2024
|
|
2023
|
Net
Sales
|
|
|
|
|
|
|
|
Wet Shave
|
$
316.3
|
|
$
324.1
|
|
$
911.1
|
|
$
908.0
|
Sun and Skin
Care
|
256.9
|
|
244.9
|
|
608.1
|
|
567.5
|
Feminine
Care
|
74.6
|
|
81.0
|
|
216.9
|
|
242.0
|
Total net
sales
|
$
647.8
|
|
$
650.0
|
|
$
1,736.1
|
|
$
1,717.5
|
|
|
|
|
|
|
|
|
Segment
Profit
|
|
|
|
|
|
|
|
Wet Shave
|
$
47.6
|
|
$
32.3
|
|
$
141.7
|
|
$
103.4
|
Sun and Skin
Care
|
64.2
|
|
61.4
|
|
117.3
|
|
114.7
|
Feminine
Care
|
6.6
|
|
14.0
|
|
22.6
|
|
38.1
|
Total segment
profit
|
118.4
|
|
107.7
|
|
281.6
|
|
256.2
|
General corporate and
other expenses
|
(15.8)
|
|
(15.8)
|
|
(47.0)
|
|
(48.7)
|
Amortization of
intangibles
|
(7.7)
|
|
(7.8)
|
|
(23.3)
|
|
(23.2)
|
Interest and other
expense, net
|
(17.2)
|
|
(15.4)
|
|
(60.4)
|
|
(53.3)
|
Restructuring and
repositioning expenses
|
(3.2)
|
|
(3.1)
|
|
(13.2)
|
|
(8.9)
|
Acquisition and
integration costs
|
(0.7)
|
|
(1.0)
|
|
(2.1)
|
|
(5.1)
|
Sun Care reformulation
costs
|
(1.3)
|
|
(0.6)
|
|
(2.2)
|
|
(1.7)
|
Wet Ones manufacturing
plant fire
|
(2.7)
|
|
—
|
|
(8.0)
|
|
—
|
Legal
matters
|
(2.5)
|
|
6.8
|
|
(3.9)
|
|
6.3
|
Loss on
investment
|
(3.1)
|
|
—
|
|
(3.1)
|
|
—
|
Defined benefit
settlement loss
|
—
|
|
—
|
|
—
|
|
(7.2)
|
Other project
costs
|
(1.7)
|
|
—
|
|
(2.9)
|
|
—
|
Total earnings
before income taxes
|
$
62.5
|
|
$
70.8
|
|
$
115.5
|
|
$
114.4
|
Refer to Note 2 - GAAP to Non-GAAP Reconciliations for the
income statement location of non-GAAP adjustments to earnings
before income taxes.
Note 2 — GAAP to Non-GAAP Reconciliations
The following tables provide a GAAP to Non-GAAP reconciliation
of certain line items from the Condensed Consolidated Statement of
Earnings:
|
Three Months Ended
June 30, 2024
|
|
Gross
Profit
|
|
SG&A
|
|
Operating
Income
|
|
EBIT (1)
|
|
Income
taxes
|
|
Net
Earnings
|
|
Diluted
EPS
|
GAAP —
Reported
|
$ 287.1
|
|
$ 110.1
|
|
$ 82.7
|
|
$
62.5
|
|
$
13.5
|
|
$ 49.0
|
|
$
0.98
|
Restructuring and
repositioning expenses
|
—
|
|
0.1
|
|
3.2
|
|
3.2
|
|
0.8
|
|
2.4
|
|
0.04
|
Acquisition and
integration costs
|
—
|
|
0.7
|
|
0.7
|
|
0.7
|
|
0.2
|
|
0.5
|
|
0.01
|
Sun Care reformulation
costs
|
—
|
|
—
|
|
1.3
|
|
1.3
|
|
0.3
|
|
1.0
|
|
0.02
|
Wet Ones manufacturing
plant fire
|
2.7
|
|
—
|
|
2.7
|
|
2.7
|
|
0.7
|
|
2.0
|
|
0.04
|
Legal
matters
|
—
|
|
2.5
|
|
2.5
|
|
2.5
|
|
0.7
|
|
1.8
|
|
0.04
|
Loss on
investment
|
—
|
|
—
|
|
—
|
|
3.1
|
|
—
|
|
3.1
|
|
0.06
|
Other project
costs
|
—
|
|
1.7
|
|
1.7
|
|
1.7
|
|
0.3
|
|
1.4
|
|
0.03
|
Total Adjusted
Non-GAAP
|
$ 289.8
|
|
$ 105.1
|
|
$ 94.8
|
|
$
77.7
|
|
$
16.5
|
|
$ 61.2
|
|
$
1.22
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted Non-GAAP
Constant Currency
|
|
$
1.28
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP as a percent of
net sales
|
44.3 %
|
|
17.0 %
|
|
12.8 %
|
|
GAAP effective tax
rate
|
21.6 %
|
|
|
Adjusted as a percent
of net sales
|
44.7 %
|
|
16.2 %
|
|
14.6 %
|
|
Adjusted effective tax
rate
|
21.2 %
|
|
|
Adjusted Constant
Currency as a percent of net sales
|
44.8 %
|
|
|
|
14.8 %
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
June 30, 2023
|
|
Gross
Profit
|
|
SG&A
|
|
Operating
Income
|
|
EBIT (1)
|
|
Income
taxes
|
|
Net
Earnings
|
|
Diluted
EPS
|
GAAP —
Reported
|
$ 280.3
|
|
$ 96.3
|
|
$ 86.2
|
|
$
70.8
|
|
$
17.8
|
|
$ 53.0
|
|
$
1.02
|
Restructuring and
repositioning expenses
|
—
|
|
0.1
|
|
3.1
|
|
3.1
|
|
0.8
|
|
2.3
|
|
0.04
|
Acquisition and
integration costs
|
—
|
|
1.0
|
|
1.0
|
|
1.0
|
|
0.2
|
|
0.8
|
|
0.02
|
Sun Care reformulation
costs
|
—
|
|
—
|
|
0.6
|
|
0.6
|
|
0.2
|
|
0.4
|
|
0.01
|
Legal
matters
|
—
|
|
(6.8)
|
|
(6.8)
|
|
(6.8)
|
|
(1.6)
|
|
(5.2)
|
|
(0.10)
|
Total Adjusted
Non-GAAP
|
$ 280.3
|
|
$ 102.0
|
|
$ 84.1
|
|
$
68.7
|
|
$
17.4
|
|
$ 51.3
|
|
$
0.99
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP as a percent of
net sales
|
43.1 %
|
|
14.8 %
|
|
13.3 %
|
|
GAAP effective tax
rate
|
25.3 %
|
|
|
Adjusted as a percent
of net sales
|
43.1 %
|
|
15.7 %
|
|
12.9 %
|
|
Adjusted effective tax
rate
|
25.3 %
|
|
|
|
(1) EBIT is
defined as Earnings before Income taxes.
|
|
Nine Months Ended
June 30, 2024
|
|
Gross
Profit
|
|
SG&A
|
|
Operating
Income
|
|
EBIT (1)
|
|
Income
taxes
|
|
Net
Earnings
|
|
Diluted
EPS
|
GAAP —
Reported
|
$ 742.9
|
|
$ 320.9
|
|
$ 178.9
|
|
$
115.5
|
|
$
25.7
|
|
$ 89.8
|
|
$
1.79
|
Restructuring and
repositioning expenses
|
—
|
|
0.1
|
|
13.2
|
|
13.2
|
|
3.3
|
|
9.9
|
|
0.20
|
Acquisition and
integration costs
|
—
|
|
2.1
|
|
2.1
|
|
2.1
|
|
0.5
|
|
1.6
|
|
0.03
|
Sun Care reformulation
costs
|
—
|
|
—
|
|
2.2
|
|
2.2
|
|
0.5
|
|
1.7
|
|
0.03
|
Wet Ones manufacturing
plant fire
|
8.0
|
|
—
|
|
8.0
|
|
8.0
|
|
2.0
|
|
6.0
|
|
0.12
|
Legal
matters
|
—
|
|
3.9
|
|
3.9
|
|
3.9
|
|
1.0
|
|
2.9
|
|
0.06
|
Loss on
investment
|
—
|
|
—
|
|
—
|
|
3.1
|
|
—
|
|
3.1
|
|
0.06
|
Other project
costs
|
—
|
|
2.9
|
|
2.9
|
|
2.9
|
|
0.7
|
|
2.2
|
|
0.04
|
Total Adjusted
Non-GAAP
|
$ 750.9
|
|
$ 311.9
|
|
$ 211.2
|
|
$
150.9
|
|
$
33.7
|
|
$ 117.2
|
|
$
2.33
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted Non-GAAP
Constant Currency
|
|
$
2.41
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP as a percent of
net sales
|
42.8 %
|
|
18.5 %
|
|
10.3 %
|
|
GAAP effective tax
rate
|
22.2 %
|
|
|
Adjusted as a percent
of net sales
|
43.3 %
|
|
18.0 %
|
|
12.2 %
|
|
Adjusted effective tax
rate
|
22.3 %
|
|
|
Adjusted Constant
Currency as a percent of net sales
|
43.2 %
|
|
|
|
12.1 %
|
|
|
|
|
|
|
|
|
|
Nine Months Ended
June 30, 2023
|
|
Gross
Profit
|
|
SG&A
|
|
Operating
Income
|
|
EBIT (1)
|
|
Income
taxes
|
|
Net
Earnings
|
|
Diluted
EPS
|
GAAP —
Reported
|
$ 712.2
|
|
$ 297.2
|
|
$ 174.9
|
|
$
114.4
|
|
$
29.6
|
|
$ 84.8
|
|
$
1.63
|
Restructuring and
repositioning expenses
|
0.2
|
|
0.2
|
|
9.1
|
|
9.1
|
|
2.4
|
|
6.7
|
|
0.13
|
Acquisition and
integration costs
|
—
|
|
5.1
|
|
5.1
|
|
5.1
|
|
1.2
|
|
3.9
|
|
0.08
|
Sun Care reformulation
costs
|
—
|
|
—
|
|
1.7
|
|
1.7
|
|
0.4
|
|
1.3
|
|
0.02
|
Legal
matters
|
—
|
|
(6.3)
|
|
(6.3)
|
|
(6.3)
|
|
(1.5)
|
|
(4.8)
|
|
(0.09)
|
Defined benefit
settlement loss
|
—
|
|
—
|
|
—
|
|
7.2
|
|
1.9
|
|
5.3
|
|
0.10
|
Total Adjusted
Non-GAAP
|
$ 712.4
|
|
$ 298.2
|
|
$ 184.5
|
|
$
131.2
|
|
$
34.0
|
|
$ 97.2
|
|
$
1.87
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP as a percent of
net sales
|
41.5 %
|
|
17.3 %
|
|
10.2 %
|
|
GAAP effective tax
rate
|
25.9 %
|
|
|
Adjusted as a percent
of net sales
|
41.5 %
|
|
17.4 %
|
|
10.7 %
|
|
Adjusted effective tax
rate
|
25.9 %
|
|
|
|
(1) EBIT is
defined as Earnings before Income taxes.
|
Note 3 - Net Sales and Profit by Segment
Operations for the Company are reported via three Segments. The
following tables present changes in net sales and segment profit
for the three and nine months ended June 30,
2024, as compared to the corresponding period in the prior
year quarter.
Net
Sales
|
Quarter Ended
June 30, 2024
|
|
Wet
Shave
|
|
Sun and
Skin
Care
|
|
Feminine
Care
|
|
Total
|
Net Sales - Q3
2023
|
$
324.1
|
|
|
|
$
244.9
|
|
|
|
$ 81.0
|
|
|
|
$
650.0
|
|
|
Organic
|
(2.0)
|
|
(0.6) %
|
|
12.4
|
|
5.1 %
|
|
(6.4)
|
|
(7.9) %
|
|
4.0
|
|
0.6 %
|
Impact of
currency
|
(5.8)
|
|
(1.8) %
|
|
(0.4)
|
|
(0.2) %
|
|
—
|
|
— %
|
|
(6.2)
|
|
(0.9) %
|
Net Sales - Q3
2024
|
$
316.3
|
|
(2.4) %
|
|
$
256.9
|
|
4.9 %
|
|
$ 74.6
|
|
(7.9) %
|
|
$
647.8
|
|
(0.3) %
|
|
Net
Sales
|
Nine Months
Ended June 30, 2024
|
|
Wet
Shave
|
|
Sun and
Skin
Care
|
|
Feminine
Care
|
|
Total
|
Net Sales - Q3
2023
|
$
908.0
|
|
|
|
$
567.5
|
|
|
|
$
242.0
|
|
|
|
$ 1,717.5
|
|
|
Organic
|
6.5
|
|
0.7 %
|
|
37.6
|
|
6.6 %
|
|
(25.1)
|
|
(10.4) %
|
|
19.0
|
|
1.1 %
|
Impact of
currency
|
(3.4)
|
|
(0.4) %
|
|
3.0
|
|
0.6 %
|
|
—
|
|
— %
|
|
(0.4)
|
|
— %
|
Net Sales - Q3
2024
|
$
911.1
|
|
0.3 %
|
|
$
608.1
|
|
7.2 %
|
|
$
216.9
|
|
(10.4) %
|
|
$ 1,736.1
|
|
1.1 %
|
|
Segment
Profit
|
Quarter Ended
June 30, 2024
|
|
Wet
Shave
|
|
Sun and
Skin
Care
|
|
Feminine
Care
|
|
Total
|
Segment Profit - Q3
2023
|
$ 32.3
|
|
|
|
$ 61.4
|
|
|
|
$ 14.0
|
|
|
|
$
107.7
|
|
|
Organic
|
17.5
|
|
54.2 %
|
|
2.8
|
|
4.6 %
|
|
(7.4)
|
|
(52.9) %
|
|
12.9
|
|
12.0 %
|
Impact of
currency
|
(2.2)
|
|
(6.8) %
|
|
—
|
|
— %
|
|
—
|
|
— %
|
|
(2.2)
|
|
(2.1) %
|
Segment Profit - Q3
2024
|
$ 47.6
|
|
47.4 %
|
|
$ 64.2
|
|
4.6 %
|
|
$ 6.6
|
|
(52.9) %
|
|
$
118.4
|
|
9.9 %
|
|
Segment
Profit
|
Nine Months
Ended June 30, 2024
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Wet
Shave
|
|
Sun and
Skin
Care
|
|
Feminine
Care
|
|
Total
|
Segment Profit - Q3
2023
|
$
103.4
|
|
|
|
$
114.7
|
|
|
|
$ 38.1
|
|
|
|
$
256.2
|
|
|
Organic
|
38.7
|
|
37.4 %
|
|
1.0
|
|
0.9 %
|
|
(15.4)
|
|
(40.4) %
|
|
24.3
|
|
9.5 %
|
Impact of
currency
|
(0.4)
|
|
(0.4) %
|
|
1.6
|
|
1.4 %
|
|
(0.1)
|
|
(0.3) %
|
|
1.1
|
|
0.4 %
|
Segment Profit - Q3
2024
|
$
141.7
|
|
37.0 %
|
|
$
117.3
|
|
2.3 %
|
|
$ 22.6
|
|
(40.7) %
|
|
$
281.6
|
|
9.9 %
|
For all tables, the impact of currency to segment profit
includes both the translational and transactional currency changes
during the quarter.
Note 4 - Net Debt and EBITDA
The Company reports financial results on a GAAP and adjusted
basis. The tables below are used to reconcile Net Debt and Net
earnings to EBITDA and Adjusted EBITDA, which are non-GAAP
measures, to improve comparability of results between periods.
|
June 30,
2024
|
|
September
30,
2023
|
Notes
payable
|
$
21.4
|
|
$
19.5
|
Long-term
debt
|
1,290.4
|
|
1,360.7
|
Gross debt
|
$
1,311.8
|
|
$
1,380.2
|
Less: Cash and cash
equivalents
|
196.1
|
|
216.4
|
Net debt
|
$
1,115.7
|
|
$
1,163.8
|
|
|
Three Months
Ended
June
30,
|
|
Nine Months
Ended
June
30,
|
|
2024
|
|
2023
|
|
2024
|
|
2023
|
Net
earnings
|
$
49.0
|
|
$
53.0
|
|
$
89.8
|
|
$
84.8
|
Income tax
provision
|
13.5
|
|
17.8
|
|
25.7
|
|
29.6
|
Interest expense,
net
|
17.8
|
|
18.5
|
|
56.6
|
|
58.5
|
Depreciation and
amortization
|
21.7
|
|
22.5
|
|
66.6
|
|
68.1
|
EBITDA
|
$
102.0
|
|
$
111.8
|
|
$
238.7
|
|
$
241.0
|
|
|
|
|
|
|
|
|
Restructuring and
repositioning expenses
|
3.2
|
|
3.1
|
|
13.2
|
|
9.1
|
Acquisition and
integration costs
|
0.7
|
|
1.0
|
|
2.1
|
|
5.1
|
Sun Care reformulation
costs
|
1.3
|
|
0.6
|
|
2.2
|
|
1.7
|
Wet Ones manufacturing
plant fire
|
2.7
|
|
—
|
|
8.0
|
|
—
|
Legal
matters
|
2.5
|
|
(6.8)
|
|
3.9
|
|
(6.3)
|
Loss on
investment
|
3.1
|
|
—
|
|
3.1
|
|
—
|
Defined benefit
settlement loss
|
—
|
|
—
|
|
—
|
|
7.2
|
Other project
costs
|
1.7
|
|
—
|
|
2.9
|
|
—
|
Adjusted
EBITDA
|
$
117.2
|
|
$
109.7
|
|
$
274.1
|
|
$
257.8
|
|
|
|
|
|
|
|
|
Adjusted EBITDA
Constant Currency
|
$
121.2
|
|
|
|
$
279.6
|
|
|
Note 5 - Outlook
The following tables provide reconciliations of Adjusted EPS and
Adjusted EBITDA, Non-GAAP measures, included within the Company's
outlook for projected fiscal 2024 results:
Adjusted EPS
Outlook
|
|
|
Fiscal 2024 GAAP
EPS
|
approx.
|
$2.28
|
|
|
|
Restructuring and
repositioning costs
|
approx.
|
0.39
|
Acquisition and
integration costs
|
approx.
|
0.06
|
Sun Care reformulation
costs
|
approx.
|
0.11
|
Wet Ones manufacturing
plant fire
|
approx.
|
0.18
|
Legal
matters
|
approx.
|
0.08
|
Loss on
investment
|
approx.
|
0.06
|
Other costs
|
approx.
|
0.08
|
Income
taxes(1)
|
approx.
|
(0.24)
|
|
|
|
Fiscal 2024 Adjusted
EPS Outlook (Non-GAAP)
|
approx.
|
$3.00
|
(1) Income tax effect
of the adjustments to Fiscal 2024 GAAP EPS noted above.
|
|
Adjusted EBITDA
Outlook
|
|
|
Fiscal 2024 GAAP Net
Income
|
approx.
|
$115
|
Income tax
provision
|
approx.
|
30
|
Interest expense,
net
|
approx.
|
74
|
Depreciation and
amortization
|
approx.
|
90
|
EBITDA
|
approx.
|
309
|
|
|
|
Restructuring and
repositioning costs
|
approx.
|
19
|
Acquisition and
integration costs
|
approx.
|
3
|
Sun Care reformulation
costs
|
approx.
|
5
|
Wet Ones manufacturing
plant fire
|
approx.
|
9
|
Legal
matters
|
approx.
|
4
|
Loss on
investment
|
approx.
|
3
|
Other project
costs
|
approx.
|
4
|
Fiscal 2024 Adjusted
EBITDA
|
approx.
|
$356
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/edgewell-personal-care-announces-third-quarter-fiscal-2024-results-302214886.html
SOURCE Edgewell Personal Care Company